Abstract
Introduction

55
Treatment of bacterial infections is often complicated by the presence of biofilms; 56 communities of bacteria characterised by a heterogeneous composition and 57 tolerance to antimicrobial treatment 1,2 . Tolerance towards antimicrobial compounds 58 has further been linked with the emergence of mutations that confer AMR in 59 planktonic cultures 3 so it is possible that biofilm-mediated tolerance mechanisms 60 could contribute similarly. Therefore, the development of relevant biofilm models is 61 vital to understanding the interplay between biofilm tolerance mechanisms and the 62 emergence of AMR. 63 64 Two bacterial species that are commonly implicated in biofilm infections are 65
Pseudomonas aeruginosa and Staphylococcus aureus. In cystic fibrosis co-infection 66
is associated with increased inflammation and reduced therapeutic outcomes for 67 patients 4 , and in chronic wounds they are the most commonly co-isolated bacterial 68 species and linked to poorer clinical outcomes 5 . However, whether the two species 69 are co-localised or spatially partitioned remains a point of contention; in part because 70 in vitro studies suggest that the relationship of these two bacteria is often 71 antagonistic in nature [6] [7] [8] . 72
73
Although it is widely recognised that in vivo biofilms are often composed of a 74 multispecies consortium, the majority of in vitro biofilm studies fail to reflect this, 75 focusing on single species. Previous models investigating co-culture of P. 76 aeruginosa and S. aureus in vitro have frequently observed that P. aeruginosa 77 rapidly outcompetes and reduces S. aureus viability within 24 hours 7, 8 . 78
Consequently, use of these species within in vitro co-culture biofilm models is often 79 restricted to short incubation periods, such as 24 or 48 hours 7-10 , which is not 80 representative of long-term biofilm colonisation associated with chronic infection. 81
Furthermore, use of these short-term in vitro models does not address or investigate 82 factors that could improve the viability of S. aureus within a co-culture population. 83
84
There is an urgent need to investigate the impact of interspecies interactions within 85 biofilms on bacterial persistence, virulence and evolvability in order to develop novel 86 treatment strategies and circumvent the emergence of adaptive mechanisms, such 87 as those associated with AMR. In this study we aimed to develop and characterise 88 an in vitro dual-species biofilm formed by S. aureus and P. aeruginosa that is more 89 representative of chronic infection. A 240-hour co-culture model was established and 90 used to determine the impact on the antimicrobial susceptibility and individual 91 mutation rates of both bacterial species. To our knowledge, this is the first 92 documented approach using a fluctuation assay to assess short-term biofilm 93 evolvability. 94
Materials and Methods
Bacterial Strains and Growth Conditions 97
The species/strains utilised in this study were P. aeruginosa PAO1, the cystic fibrosis 98 isolate P. aeruginosa PA21, S. aureus UAMS-1 and S. aureus USA 300 LAC 99 AH1279 (supplementary Table 1 12 , was determined for mono-and co-culture biofilms of P. aeruginosa 183 PA21 and S. aureus UAMS-1 using a method adapted from Howlin et al (2015) 13 . 184
Biofilms were cultured for 72 hours in Nunclon coated 6 well plates as previously 185 To demonstrate that the biofilm model could be utilised in phenotyping experiments 430 the antimicrobial susceptibility of established mono-and co-culture biofilms of S. 431 aureus UAMS-1 and P. aeruginosa PA21 was determined using two antimicrobials in 432 clinical use (tobramycin and vancomycin) and a novel antimicrobial compound 433 currently in development (HT61). 434 435 Whereas vancomycin and HT61 had no effect on P. aeruginosa viability when grown 436 as either a single or dual-species biofilm, the MBC of tobramycin increased from 2 to 437 4 g ml -1 . Similarly, S. aureus viability was not affected by vancomycin in either 438 single or dual-species biofilms, however, the tobramycin and HT61 MBCs were 439 reduced eightfold (16 to 2 g ml -1 ) and fourfold (64 to 16 g ml -1 ) respectively. 440
Biofilm co-culture of P. aeruginosa and S. aureus significantly increases the 
Discussion and Conclusion
504
In this paper, we developed a long-term in vitro biofilm co-culture of P. aeruginosa 505 and S. aureus that could be maintained for at least 10 days and is more 506 representative of chronic infection compared to current 24-48 hour models. Following 507 optimisation of the biofilm co-culture we determined how biofilm co-culture altered 508 the evolvability of each bacterial species, and using a genomic based approach 509 compared and identified features of P. aeruginosa that could be implicated in 510 sustaining a biofilm co-culture with S. aureus. 511
512
When comparing planktonic and biofilm co-culture, we found that the viability of S. 513 aureus was only negatively affected during biofilm growth. This was interesting as 514 numerous studies have shown that the viability of S. aureus is negatively affected by 515 P. aeruginosa even in planktonic culture 10,27-29 . However, Miller et al (2017) found 516 that use of a more nutrient rich medium improved S. aureus survival 30 . This 517 suggests, consistent with our results that media composition is an important 518 consideration for the development of a co-culture model. 519
520
We found that both P. aeruginosa strain and exogenous hemin concentration 521 impacted S. aureus survival during biofilm co-culture. Altered levels of S. aureus 522 killing by P. aeruginosa has been linked to latter's ability to form biofilms; those that 523 form less biofilm are less prone to S. aureus killing 7 . Based on crystal violet staining, 524 P. aeruginosa PAO1 formed more robust single species biofilms than P. aeruginosa 525 PA21 and also reduced the number of viable S. aureus during biofilm co-culture. It 526 has been demonstrated that P. aeruginosa isolates taken from patients co-infected 527 with P. aeruginosa and S. aureus are less competitive towards S. aureus 8, 27 . While 528 the exact clinical background of P. aeruginosa PA21 in relation to S. aureus co-529 culture is not available, this could be a factor that favours its co-culture with S. 530
aureus. 531 532
We showed that increasing the concentration of hemin improved S. aureus viability 533 during co-culture with P. aeruginosa PA21. During biofilm co-culture, S. aureus is 534 lysed and used as an iron source for P. aeruginosa in a Pseudomonas quinolone 535 signal, PQS, mediated process that is decreased in iron rich environments 7, 31 . By 536 increasing the exogenous iron concentration, it is possible that P. aeruginosa PA21 537 PQS expression was reduced, reducing S. aureus lysis. Measuring the changes in 538 expression of associated genes in P. aeruginosa PA21 such as pqsA and pqsH, with 539 differing concentrations of hemin may provide insight into this scenario. 540 541 Sequencing of the two P. aeruginosa genomes identified features that could be 542 important targets for further investigation. The presence of additional iron uptake 543 components and lack of manganese catalase enzymes, (typical for bacteria 544 occupying low iron environments/possess ineffective iron uptake mechanisms) 32 , 545 may mean that PA21 at the uptake of exogenous iron than PAO1. If uptake is more 546 efficient, that could negatively regulate the production of molecules that are 547 produced to lyse S. aureus and utilise it as an iron source instead 7 . As an aside, it 548 was found that P. aeruginosa PA21 still contained genes encoding the siderophores 549 pyoverdine and pyochelin, pvdA and pchE, respectively. The presence of these 550 genes has previously been associated with increased killing of S. aureus in co-551 culture 9 . As P. aeruginosa PA21 was less lethal to S. aureus than P. aeruginosa 552 PAO1, it suggests these genes are not implicated and the improved survival is a 553 result of a different mechanism. Expression of the phd-doc TA system has been 554 linked with translation inhibition 33 . If this module is activated by PA21 during co-555 culture, it could facilitate S. aureus survival by slowing P. aeruginosa growth and/or 556 increase S. aureus tolerance. Further investigation into these elements would be 557 required. 558 559 Mutation frequency is known to be elevated in biofilms 34, 35 , which is a measure of the 560 abundance of mutants within a population. However, mutation frequency can be 561 distorted by the expansion of lineages harbouring low probability, "jackpot mutations" 562 that occur during the early stages of growth. On the other hand, mutation rate, which 563 measures the number of mutations sustained by a cell during its lifetime, accounts 564 for jackpot mutations and is overall, a more robust measurement 14 
